MRNA intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Financial Services. Listed on Saudi Exchange Tadawul.
Morabaha Marina Financing Company (MRNA) provides financing for individuals and small and medium enterprises in Saudi Arabia, operating through Retail, SME, and Digital Payments segments. Its services include finance leasing and consumer financing, alongside electronic payment and digital wallet services. The company was founded in 2012 and is headquartered in Riyadh.
TASIV estimates this company's intrinsic value using a Price-to-Book (P/B) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 10.41 compared to a market price of SAR 9.33 (Trading below DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 14% over the two-year period, while net income moved in the opposite direction, declining by around 27%, meaning profitability did not track the revenue increase. Operating cash flow remained negative in both years but the shortfall narrowed by more than half, a larger proportional change than either revenue or net income showed. Overall, the company's historical financial performance shows revenue growth alongside a decline in net income and a partial narrowing of negative operating cash flow.
Dividend per share held steady at SAR 0.53 for 1 consecutive years before declining to SAR 0.35 in the most recent year, a decrease of about 34%. Payments have been made on an Annual basis throughout this period. Overall, the dividend held flat for most of the period before a recent decline. Current dividend yield is approximately 3.75%, with a payout ratio of approximately 109.94%.
Based on TASIV's Price-to-Book (P/B) model, the estimated intrinsic value of MRNA is approximately SAR 10.41, compared to a current market price of SAR 9.33. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, MRNA is currently "Trading below DCF model value".
MRNA's dividend yield is approximately 3.75%, with a payout ratio of approximately 109.94%, based on TASIV's most recent verified data.
Loading 4082...